Heather S. Bonner - Concepedia

Author

Heather S. Bonner

University of Pennsylvania

Also Known As

H Bonner, H S Bonner, H. Bonner, H. S. Bonner, H.S. Bonner, Heather Bonner, Heather S Bonner, Heather S. Bonner

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Hospital of the University of Pennsylvania Wayne State University California University of Pennsylvania

About

Heather S. Bonner is an author at University of Pennsylvania specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.3K
2	Biochemistry	6	6	392
3	Health Sciences	3	3	222
4	Engineering	2	2	39
5	Natural Sciences	1	1	17

Heather S. Bonner

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Nonlymphomatous Malignant Tumors Complicating Hodgkin's Disease James C. Arseneau, Robert W. Sponzo, David L. Levin, New England Journal of Medicine Lymphoid NeoplasiaSecond Malignant TumorsTumoral PathologyRadiation TherapyAbstract Case Records	1972	353
Cytochrome c2 and reaction center of Rhodospeudomonas spheroides Ga. membranes. Extinction coefficients, content, half-reduction potentials, kinetics and electric field alterations P. Leslie Dutton, K.M. Petty, Heather S. Bonner, Biochimica et Biophysica Acta (BBA) - Bioenergetics Half-reduction PotentialsBiochemistryBioelectrochemistryBioenergeticsElectric Field Alterations	1975	242
Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly. S. Benham Kahn, C B Begg, J. J. Mazza, Journal of Clinical Oncology Elderly PatientsPharmacotherapyFull Dose VersusMetronomic ChemotherapyEarly Death Rate	1984	145
Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial. Bruce G. Raphael, J. W. Andersen, R Silber, Journal of Clinical Oncology Hematological MalignancyLymphoid NeoplasiaEligible PatientsChronic Lymphocytic LeukemiaMedicine	1991	130
Human pharmacokinetics of WR-2721 Andrew T. Turrisi, Donna Glover, Heather S. Bonner, International Journal of Radiation OncologyBiologyPhysics Human PharmacokineticsPharmacologyClinical PharmacologyPharmacotherapyMedicine	1986	93
Lymphoid infiltration and amyloidosis of lung in Sjögren's syndrome. Heather S. Bonner, Ennis Rs, Geelhoed Gw, PubMed RheumatologyAutoimmune DiseaseSjögren’s SyndromeHistopathologyImmunology	1973	73
Pharmacokinetics of amifostine: effects of dose and method of administration. Heather S. Bonner, Lynn M. Schuchter, Joan H. Schiller, PubMed	1999	57
Metabolic pathways of WR-2721 (ethyol, amifostine) in the BALB/c mouse. Yi‐Ju Li, Heather S. Bonner, D Q Brown PubMed Redox BiologyToxicological MechanismOxidative StressRadiopharmaceutical TherapyToxicology	1994	54
New Dosing Regimens for Amifostine: A Pilot Study to Compare the Relative Bioavailability of Oral and Subcutaneous Administration with Intravenous Infusion Heather S. Bonner, Leslie M. Shaw The Journal of Clinical Pharmacology	2002	48
A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury Edgar Ben‐Josef, Sue Han, Martin Tobi, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyTopical DrugSurgeryWound Healing	2002	48

Page 1